Lactose (India) Ltd

Lactose (India) Limited has fixed Monday, November 02, 2026, as the record date for determining the entitlement of equity shareholders of Vitanosh Ingredients Private Limited to the allotment of fully paid-up equity shares of face value of Rs 10 each of Lactose (India) Limited, pursuant to a scheme of amalgamation approved by the National Company Law Tribunal, Ahmedabad Bench, on August 05, 2026. The share exchange ratio under the scheme is 0.7946 equity shares of Lactose (India) Limited for every 1 equity share held in Vitanosh Ingredients Private Limited.

Lactose (India) Limited submitted a certificate to the BSE Limited on October 14, 2026, confirming the details of securities dematerialized during the quarter ended September 30, 2026, as required under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, with confirmation from Bigshare Services Private Limited acting as the Registrar and Share Transfer Agent.

Lactose (India) Limited informed the BSE that shareholders approved the appointment of Alpesh A. Lakeshri as Cost Auditor for the financial year ending March 31, 2027, at a meeting held on September 30, 2026. Lakeshri, a practicing Cost Accountant since August 2023, is also the Cost Auditor for several other companies including Alivira Healthcare Private Limited and Piramal Pharma Limited.

Lactose (India) Limited informed the BSE Limited that the trading window for the company's securities will be closed from Thursday, October 1, 2026, and will reopen 48 hours after the public announcement of the un-audited financial results for the quarter ended September 30, 2026; the date of the board meeting to consider the results will be intimated later.

Lactose (India) Limited announced that Vitanosh Ingredients Private Limited and Lactose (India) Limited have filed the certified copy of the National Company Law Tribunal order, sanctioning their scheme of amalgamation with the respective jurisdictional Registrar of Companies, effective September 5, 2026.

Lactose (India) Limited informed the BSE that its board approved the reappointment of M/s. AMS & Co. Chartered Accountants as internal auditors for the financial year 2026-2027, and appointed Alpesh A. Lakeshri as cost auditor for the same period, both effective August 25, 2026. The board also approved the director’s report for the financial year 2025-2026, remuneration for Managing Director Mr. Atul Maheshwari and Whole Time Director Mrs. Sangita Maheshwari, and appointed Bigshare Services Private Limited for e-voting facility for the upcoming Annual General Meeting.

Lactose (India) Limited informed the BSE Limited on Tuesday, August 25, 2026, that its board of directors approved the reappointment of M/S. AMS & CO LLP Chartered Accountants as internal auditors for the financial year 2026-2027, and the appointment of Alpesh A. Lakeshri as cost auditor for the same period.

Lactose (India) Limited informed the BSE on August 25, 2026, that its board approved the reappointment of M/s. AMS & Co. Chartered Accountants as internal auditors for the financial year 2026-2027, and appointed Alpesh A. Lakeshri as cost auditor for the same period, succeeding M/s. Kirit Mehta & Co. The board also approved the company’s director’s report for the financial year 2025-2026, remuneration for Managing Director Mr. Atul Maheshwari and Whole Time Director Mrs. Sangita Maheshwari, and related party transactions.

Lactose (India) Limited will hold a board meeting on Tuesday, August 11, 2026, to consider and approve the unaudited financial results for the first quarter ended June 30, 2026, along with a limited review report from its statutory auditor, according to a regulatory filing with the BSE Limited. The trading window for the company's securities has been closed for directors, officers, and designated employees since July 1, 2026, and will reopen 48 hours after the financial results are declared.

Lactose (India) will hold a meeting of the Board of Directors of the Company on 18 June 2026.